Article Versions Notes

Bouchard A, Sikner H, Baverel V, Garnier A-R, Monterrat M, Moreau M, Limagne E, Garrido C, Kohli E, Collin B, et al. The GRP94 Inhibitor PU-WS13 Decreases M2-like Macrophages in Murine TNBC Tumors: A Pharmaco-Imaging Study with ^99mTc-Tilmanocept SPECT. Cells. 2021; 10(12):3393. https://doi.org/10.3390/cells10123393

Bouchard, Alexanne, Hugo Sikner, Valentin Baverel, Anaïs-Rachel Garnier, Marie Monterrat, Mathieu Moreau, Emeric Limagne, Carmen Garrido, Evelyne Kohli, Bertrand Collin, and et al. 2021. "The GRP94 Inhibitor PU-WS13 Decreases M2-like Macrophages in Murine TNBC Tumors: A Pharmaco-Imaging Study with ^99mTc-Tilmanocept SPECT" Cells 10, no. 12: 3393. https://doi.org/10.3390/cells10123393

Bouchard, A., Sikner, H., Baverel, V., Garnier, A. -R., Monterrat, M., Moreau, M., Limagne, E., Garrido, C., Kohli, E., Collin, B., & Bellaye, P. -S. (2021). The GRP94 Inhibitor PU-WS13 Decreases M2-like Macrophages in Murine TNBC Tumors: A Pharmaco-Imaging Study with ^99mTc-Tilmanocept SPECT. Cells, 10(12), 3393. https://doi.org/10.3390/cells10123393